CAS: 1365287-97-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Emibetuzumab REF: TM-T76743CAS: 1365287-97-3 | SDS-PAGE:96.2%;SEC-HPLC:98.8% | 142.00 €~662.00 € | Thu 18 Jul 24 |
 | Emibetuzumab REF: 3D-CLA1359CAS: 1365287-97-3 | - - - | To inquire | Tue 30 Jul 24 |
Emibetuzumab
CAS:1365287-97-3
Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.
Purity:
SDS-PAGE:96.2%;SEC-HPLC:98.8%
Color and Shape:
Solid
Ref: TM-T76743
| 1mg | 142.00 € | ||
| 5mg | 416.00 € | ||
| 10mg | 662.00 € |
Estimated delivery in United States, on Thursday 18 Jul 2024
Ref: 3D-CLA1359
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 30 Jul 2024
